Scientists have cracked a 35-year-old mystery about the workings of a revolving molecular motor that is now serving as a model for development of a futuristic genre of synthetic nanomotors that pump therapeutic DNA, RNA, or drugs into individual diseased cells. Their report reveals the mechanisms of these nanomotors in a bacteria-killing virus—and a new way to move DNA through cells
A compact, self-contained sensor recorded and transmitted brain activity data wirelessly for more than a year in early stage animal tests, according to a recent study funded by the National Institutes of Health. In addition to allowing for more natural studies of brain activity in moving subjects, this implantable device represents a potential major step toward cord-free control of advanced prosthetics that move with the power of thought
Microbes from the human mouth are telling Oak Ridge National Laboratory scientists something about periodontitis and more after they cracked the genetic code of bacteria linked to the condition. The research marks the first time scientists have managed to isolate and cultivate this type of bacterium.
This week, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Sony DADC announced a collaboration that will harness Sony DADC's global manufacturing expertise to further advance the Institute's Organs-on-Chips technologies. Human Organs-on-Chips are research tools composed of a clear, flexible polymer about the size of a computer memory stick, and contain hollow microfluidic channels lined by living human cells
A new online database combining symptoms, family history and genetic sequencing information is speeding the search for diseases caused by a single rogue gene. As described in an article in the May issue of Human Mutation, the database, known as PhenoDB, enables any clinician to document cases of unusual genetic diseases for analysis by researchers at the Johns Hopkins University School of Medicine or the Baylor College of Medicine.
Archaeologists recently unearthed a “Black Death” grave in London, containing more than a dozen skeletons of people suspected to have died from the plague. The victims are thought to have died during the 14th century and archaeologists anticipate finding many more as they excavate the site. Results of their reveal a number of factors that show we are still at risk of plague today.
A research team at the National Institute of Materials Science in Japan has recently developed a gel material which is capable of releasing drugs in response to pressure applied by the patient. Three fingers applying force to the site of the gel produces an effect for up to three days. They built the new drug from two materials already used in pharmaceuticals: a saccharide and a natural component of algae.
Engineers at Stanford have developed a prototype single-fiber endoscope that improves the resolution of these much-sought-after instruments fourfold over existing designs. This so-called micro-endoscope can resolve objects just 2.5 micrometers in size and could lead to an era of needle-thin, minimally invasive endoscopes able to view features out of reach of today’s instruments.
An RTI International-developed prototype catheter that can generate live, streaming 3D ultrasound images from inside the heart has recently received a Cardiovascular Innovation Award at the 2013 Cardiovascular Research Technologies Annual Symposium. Called a live volumetric imaging intracardiac catheter, the technology has the potential to improve catheter-based heart procedures.
The future is unclear for a promising heart device aimed at preventing strokes in people at high risk of them because of an irregular heartbeat. Early results from a key study of Boston Scientific Corp.'s Watchman device suggested it is safer than previous testing found, but may not be better than a drug that is used now for preventing strokes, heart-related deaths and blood clots in people with atrial fibrillation over the long term.
Can the length of strands of DNA in patients with heart disease predict their life expectancy? Researchers from the Intermountain Heart Institute at Intermountain Medical Center in Salt Lake City, who studied the DNA of more than 3,500 patients with heart disease, say yes it can.
Protein activity is strictly regulated. Incorrect or poor protein regulation can lead to uncontrolled growth and thus cancer or chronic inflammation. Researchers in Switzerland have identified enzymes that can regulate the activity of medically important proteins. Their discovery enables these proteins to be manipulated very selectively, opening up new treatment methods.
Early detection is vital for the effective treatment of cancer. In many cases, tell-tale biomarkers are present in the bloodstream long before outward symptoms become apparent. The development of an inexpensive and rapid point-of-care diagnostic test capable of spotting such early biomarkers of disease could save many lives. A research team in Japan working on developing such a test has now produced their most sensitive microRNA detector yet.
According to findings by researchers at Washington University School of Medicine in St. Louis, nanoparticles carrying a toxin found in bee venom can destroy human immunodeficiency virus (HIV) while leaving surrounding cells unharmed. The finding is an important step toward developing a vaginal gel that may prevent the spread of HIV, the virus that causes AIDS.
A research team with members and Canada and the United States have discovered that a "gateway" known to control the movement of molecules in and out of a cell's nucleus appears to play another critically important role. Its second job is the ability to control the structure of chromosomes and the DNA linked to those chromosomes. This impacts what genes produce or express.
Health officials are reporting an alarming increase in some dangerous superbugs at U.S. hospitals. These superbugs from a common germ family have become extremely resistant to treatment with antibiotics. Only 10 years ago, such resistance was hardly ever seen in this group. Infections from these superbugs are still uncommon. But in the first six months of last year, nearly 200 U.S. hospitals saw at least one case.
Tiny biomolecular chambers called nanopores that can be selectively heated may help doctors diagnose disease more effectively if recent research by a team at NIST proves effective. The team has pioneered work on the use of nanopores for the detection and identification of a wide range of molecules, including DNA. These nanopores mimic ion channels, the gateways by which a cell admits and expels materials.
It was one of the most dramatic stories from Superstorm Sandy: More than 300 patients including tiny babies safely removed from a flooded New York hospital that lost power. But in a research building at the complex, where thousands of lab mice were kept, the story had a sadder ending. A storm surge into the basement swamped some 7,000 cages of mice used for studying cancer, diabetes, brain development and other health issues. About 50 scientists at the Langone Medical Center are going through the slow process of replacing them
A simple new method better assesses the risks posed by emerging zoonotic viruses Researchers show that the new tool can produce transmissibility estimates for swine flu, allowing researchers to better evaluate the possible pandemic threat posed by this virus. ntil now, estimates of transmissibility were derived from detailed outbreak investigations, which are resource intensive and subject to selection bias.
According to a study by Cornell University neuroscientist Nathan Spreng and his colleagues, it is possible to tell who a person is thinking about by analyzing images of his or her brain. Our mental models of people produce unique patterns of brain activation, which can be detected using advanced imaging techniques such as functionalized magnetic resonance imaging (fMRI).
Therapeutic and diagnostic in function, so-called “theranostic” particles have been developed by a team in Sweden. These small particles can be loaded with medicine and could be a future weapon for cancer treatment. Because the particles can be seen in magnetic resonance images, they are traceable.
Scientists in Australia are perfecting a technique that may help see nanodiamonds used in biomedical applications. They have been processing the raw diamonds so that they might be used as a tag for biological molecules and as a probe for single-molecule interactions. With the help of an international team, these diamonds have recently been optically trapped and manipulated in three dimensions—the first time this has been achieved.
In systemic lupus erythematosus, the body attacks itself for largely mysterious reasons, leading to serious tissue inflammation and organ damage. Current drug treatments address symptoms only and can require life-long daily use at toxic doses. Now, scientists at Yale University have designed and tested a drug delivery system that uses biodegradable nanoparticles to deliver low drug doses. The method shows early promise for improved treatment of lupus and other chronic, uncured autoimmune diseases.
A new study has examined how bacteria clog medical devices, and the result isn’t pretty. The microbes join to create slimey ribbons that tangle and trap other passing bacteria, creating a full blockage in a startlingly short period of time. The finding could help shape strategies for preventing clogging of devices such as stents and water filters
A homebrewed diagnostic mixture containing a single drop of blood, a dribble of water, and a dose of DNA powder with gold particles could mean rapid diagnosis and treatment of the world's leading diseases in the near future. The cocktail diagnostic is being developed at the University of Toronto and it involves the same technology used in over-the-counter pregnancy tests.